Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stake Lifted by Riverview Trust Co

Riverview Trust Co raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 123.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,874 shares of the pharmacy operator’s stock after purchasing an additional 1,590 shares during the quarter. Riverview Trust Co’s holdings in Walgreens Boots Alliance were worth $27,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. State Street Corp lifted its stake in shares of Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP acquired a new position in Walgreens Boots Alliance in the third quarter worth about $24,226,000. Thompson Siegel & Walmsley LLC raised its holdings in shares of Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after buying an additional 934,754 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after acquiring an additional 817,762 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Trading Down 4.9 %

Shares of WBA stock opened at $10.69 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a market capitalization of $9.23 billion, a price-to-earnings ratio of -1.04, a PEG ratio of 1.31 and a beta of 0.65. The company has a 50-day simple moving average of $10.50 and a two-hundred day simple moving average of $9.72. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the prior year, the company earned $0.66 EPS. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the company from $11.00 to $9.00 in a report on Friday. Finally, Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $11.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.